Diabetic cardiomyopathy: the preclinical phase

Area of Science:

• Cardiology
• Diabetology
• Nephrology

Background:

• Insulin-requiring diabetes is associated with microvascular complications.
• Diabetic cardiomyopathy is a recognized complication, but its underlying mechanisms require further elucidation.
• Microangiopathy, a common diabetic complication, may play a role in cardiac dysfunction.

Purpose of the Study:

• To investigate left ventricular function in insulin-requiring diabetics with and without significant microangiopathy.
• To compare cardiac function between diabetic subgroups and normal controls.
• To explore the relationship between microangiopathy and impaired left ventricular function.

Main Methods:

• Systolic time intervals were measured to assess left ventricular function.
• Significant microangiopathy was defined by proteinuria (>3 g/24 h) or proliferative retinopathy.
• Echocardiography was used for follow-up assessment in a subset of patients.
• Exclusion criteria included angina, prior myocardial infarction, hypertension, and alcoholism.

Main Results:

• Diabetics with significant microangiopathy demonstrated impaired left ventricular function.
• Patients with uncomplicated diabetes showed normal left ventricular function.
• These findings suggest microangiopathy, not just metabolic defects, contributes to diabetic cardiomyopathy.

Conclusions:

• Microangiopathy is associated with impaired left ventricular function in insulin-requiring diabetics.
• This cardiac dysfunction may represent a specific diabetic cardiomyopathy.
• The link between microangiopathy and impaired heart function could explain increased cardiac mortality post-myocardial infarction in diabetics.